Device Ortho-Hip

Pinnacle

Payments companies reported to CMS as associated with Pinnacle. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$16Massociated payments (2023-2025)

112clinicians with associated payments

5companies reporting

By year

2023 $5.1M

2024 $4.3M

2025 $6.4M

Payments reported as associated with Pinnacle, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $15M

Adult Reconstructive Orthopaedic Surgery $1.1M

Cardiovascular Disease $17K

Anesthesiology $9,250

Orthopaedic Trauma $3,575

Surgical $345

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Pinnacle

These are the largest totals companies reported as associated with Pinnacle. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Daniel Berry	Rochester, MN	Orthopaedic Surgery	$8,397,885.77
William Barrett	Renton, WA	Orthopaedic Surgery	$2,181,437.88
John Callaghan	Iowa City, IA	Orthopaedic Surgery	$628,126.84
Timothy Alton	Renton, WA	Orthopaedic Surgery	$545,479.76
Thomas Schmalzried	Los Angeles, CA	Orthopaedic Surgery	$540,222.52
Craig Della Valle	Chicago, IL	Adult Reconstructive Orthopaedic Surgery	$538,466.11
Thomas Fehring	Charlotte, NC	Orthopaedic Surgery	$490,294.74
John Redmond	Jacksonville, FL	Adult Reconstructive Orthopaedic Surgery	$375,114.88
William Griffin	Charlotte, NC	Orthopaedic Surgery	$331,506.72
Charlie Yang	Denver, CO	Orthopaedic Surgery	$203,969.84

Prescribed Pinnacle?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.